|
시장보고서
상품코드
2078018
류마티스 관절염 진단 검사 시장 : 검사 종류별, 최종사용자별, 지역별Rheumatoid Arthritis Diagnostic Tests Market By Test Type (Serology Test, Monitoring RA Treatment Efficiency Tests ), By End User, By Region |
||||||
류마티스 관절염 진단 검사 시장은 2026년에 32억 5,540만 달러 규모가 될 것으로 추정되며, 2033년까지 47억 6,710만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 5.6%로 성장할 것으로 전망됩니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준 연도 | 2025년 | 시장 규모(2026년) | 32억 5,540만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2026-2033년 |
| 예측 기간 CAGR(2026-2033년) | 5.60% | 예측 금액(2033년) | 47억 6,710만 달러 |
류마티스 관절염(RA)은 자가면역성 염증성 질환입니다. 이는 면역 체계가 실수로 체내의 건강한 세포를 공격하여, 신체의 해당 부위에 염증(통증을 동반한 부기)을 일으킨다는 것을 의미합니다. RA는 주로 관절을 공격하며, 일반적으로 한 번에 여러 관절이 영향을 받습니다. RA는 손, 손목, 슬관절에서 흔히 나타납니다. RA에 걸린 관절에서는 관절 내막에 염증이 생겨 관절 조직에 손상을 입힙니다. 이 조직의 손상은 장기간 지속되거나 만성적인 통증, 불안정감(균형 감각 상실), 변형을 유발할 수 있습니다. 또한, RA는 체내의 다른 조직에도 영향을 미쳐 폐, 심장, 눈 등의 장기에 문제를 일으킬 수도 있습니다. 류마티스 관절염은 자가면역 질환으로, 면역계가 건강한 신체 조직을 공격함으로써 발생합니다. 류마티스 관절염 진단 검사 시장은 전 세계 및 지역 차원에서 사업을 전개하는 기업이 여러 곳 존재하기 때문에 그 특성상 중간 정도의 세분화가 나타납니다.
시장 역학
주요 시장 참여 기업들은 류마티스 관절염용 혈액 진단 검사 출시 등 유기적인 성장 전략을 채택하는 데 주력하고 있으며, 이는 전 세계 류마티스 관절염 진단 검사 시장의 성장에 기여하고 있습니다. 예를 들어, 2020년 3월, 의료 기술 기업인 BD(Becton, Dickinson and Company)와 노스캐롤라이나주에 본사를 둔 비상장 임상 진단 기업인 BioMedomics는 혈액 내 항체를 검출하여 현재 또는 과거의 류마티스 관절염 노출 여부를 확인할 수 있는 새로운 POC 검사를 출시한다고 발표했습니다. 이 검사는 단 15분 만에 결과를 확인할 수 있으며, 미국 및 중국의 여러 병원과 임상 검사 기관에서 임상적 유효성이 확인되었습니다.
본 보고서의 주요 특징
- 본 보고서는, 전 세계 류마티스 관절염 진단 검사 시장에 대한 상세한 분석을 제공하는 한편, 2025년을 기준 연도로 하여 예측 기간(2026-2033년) 동안의 시장 규모 및 연평균 성장률(CAGR)을 제시하고 있습니다. 또한, 각 부문의 잠재적 수익 기회를 파악하고, 이 시장의 매력적인 투자 제안에 대한 매트릭스를 설명하고 있습니다.
- 또한, 시장의 촉진요인 및 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업들이 채택하는 경쟁 전략 등에 관한 중요한 인사이트도 제공하고 있습니다.
- 전 세계 류마티스 관절염 진단 검사 시장의 주요 기업 개요을 각종 지표(기업 개요, 제품 포트폴리오, 주요 동향, 재무 실적, 전략 등)를 바탕으로 수록하고 있습니다.
- 본 보고서의 인사이트를 바탕으로, 마케팅 담당자와 기업 경영진은 향후 제품 출시, 기술 업데이트, 시장 확대 및 마케팅 전략에 대해 충분한 정보를 바탕으로 의사결정을 내릴 수 있습니다.
- '세계 류마티스 관절염 진단 검사 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 재무 분석가 등 이 업계의 다양한 이해관계자들을 대상으로 합니다.
- 이해관계자들은 전 세계 류마티스 관절염 진단 검사 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 할 수 있습니다.
목차
제1장 분석 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 류마티스 관절염 진단 검사 시장
제5장 세계의 류마티스 관절염 진단 검사 시장 : 검사 종류별(2021-2033년)
제6장 세계의 류마티스 관절염 진단 검사 시장 : 최종사용자별(2021-2033년)
제7장 세계의 류마티스 관절염 진단 검사 시장 : 지역별(2021-2033년)
제8장 경쟁 구도
제9장 섹션
KSM 26.07.15Rheumatoid Arthritis Diagnostic Tests Market is estimated to be valued at USD 3,255.4 Mn in 2026 and is expected to reach USD 4,767.1 Mn by 2033, growing at a compound annual growth rate (CAGR) of 5.6% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 3,255.4 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 5.60% | 2033 Value Projection: | USD 4,767.1 Mn |
Rheumatoid arthritis, or RA, is an autoimmune and inflammatory disease, which means that your immune system attacks healthy cells in your body by mistake, causing inflammation (painful swelling) in the affected parts of the body. RA mainly attacks the joints, usually many joints at once. RA commonly affects joints in the hands, wrists, and knees. In a joint with RA, the lining of the joint becomes inflamed, causing damage to joint tissue. This tissue damage can cause long-lasting or chronic pain, unsteadiness (lack of balance), and deformity (misshapenness).RA can also affect other tissues throughout the body and cause problems in organs such as the lungs, heart, and eyes.Rheumatoid arthritis is an autoimmune condition, which means it's caused by the immune system attacking healthy body tissue. The rheumatoid arthritis diagnostic tests market is moderately fragmented in nature due to the presence of several companies operating globally as well as regionally.
Market Dynamics
The key market players are focusing on adoption of growth organic strategies such launching of diagnostic blood test for rheumatoid arthritis, which is attributed to the growth of global rheumatoid arthritis diagnostic tests market. For instance, in March 2020, BD (Becton, Dickinson and Company) is a medical technology company, and BioMedomics, a privately held, North Carolina-based clinical diagnostics company, announced the release of a new point-of-care test that can detect antibodies in blood to confirm current or past exposure to rhumetoid arthritis in as little as 15 minutes test has been clinically validated at several hospitals and clinical laboratories in both the U.S. and China.
Key features of the study:
- This report provides an in-depth analysis of the global rheumatoid arthritis diagnostic tests market and provides market size (US$ Million) and compound annual growth rate (CAGR) for the forecast period 2026-2033, considering 2025 as the base year It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global rheumatoid arthritis diagnostic tests market based on the following parameters-Company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include include Abbott Diagnostics (Abbott Laboratories), Labcorp ,Antibodies Inc., Networks LLC, Beckman Coulter, Inc., Euro Diagnostica AB, F. Hoffmann-La Roche Ltd., Qiagen NV, Siemens Healthcare GmbH, Augurex Life Sciences Corp., Thermo Fisher Scientific Inc., Bio Rad Laboratories Inc., Exagen Inc., Genway Biotech, Inc., Microdrop LLC (imaware), Svar Life Science AB, and Thermo Fisher Scientific Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global rheumatoid arthritis diagnostic tests market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Rheumatoid Arthritis Diagnostic Tests market
Detailed Segmentation:
- Global Rheumatoid Arthritis Diagnostic Tests Market, By Test Type (Revenue, USD Mn, 2021 - 2033)
- Serology Test
- Erythrocyte Sedimentation Rate (ESR)
- Rheumatoid Factor (RF)
- Anti-cyclic Citrullinated Peptide (anti-CCP)
- Antinuclear Antibody (ANA)
- Uric Acid
- Other Tests
- Monitoring RA Treatment Efficiency Tests
- Salicylate Level Count
- Muscle Enzyme Tests (CPK, Aldolase)
- Creatinine Test
- Global Rheumatoid Arthritis Diagnostic Tests Market, By End User (Revenue, USD Mn, 2021 - 2033)
- Diagnostic Laboratories
- Private Laboratories
- Public Laboratories
- Ambulatory Surgical Centers
- Global Rheumatoid Arthritis Diagnostic Tests, By Region (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Abbott Diagnostics (Abbott Laboratories) *
- Labcorp
- Antibodies Inc.
- Networks LLC
- Beckman Coulter, Inc.
- Euro Diagnostica AB
- F. Hoffmann-La Roche Ltd.
- Qiagen NV
- Siemens Healthcare GmbH
- Augurex Life Sciences Corp.
- Thermo Fisher Scientific Inc.
- Bio Rad Laboratories Inc.
- Exagen Inc.
- Genway Biotech, Inc.
- Microdrop LLC (imaware)
- Svar Life Science AB
- Thermo Fisher Scientific Inc.
Table of Contents
1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Test Type
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Test Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
4. Global Rheumatoid Arthritis Diagnostic Tests Market
- Economic Impact
- Impact on Supply and Demand
5. Global Rheumatoid Arthritis Diagnostic Tests Market, By Test Type, 2021 €" 2033 (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022€"2033
- Segment Trends
- Serology Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 €" 2033, (US$ Mn)
- Segment Trends
- Erythrocyte Sedimentation Rate (ESR)
- Rheumatoid Factor (RF)
- Anti-cyclic Citrullinated Peptide (anti-CCP)
- Antinuclear Antibody (ANA)
- Uric Acid
- Other Tests
- Monitoring RA Treatment Efficiency Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 €" 2033, (US$ Mn)
- Segment Trends
- Salicylate Level Count
- Muscle Enzyme Tests (CPK, Aldolase)
- Creatinine Test
6. Global Rheumatoid Arthritis Diagnostic Tests Market, By End User, 2021 €" 2033 (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022€"2033
- Segment Trends
- Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 €" 2033, (US$ Mn)
- Private Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 €" 2033, (US$ Mn)
- Public Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 €" 2033, (US$ Mn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 €" 2033, (US$ Mn)
7. Global Rheumatoid Arthritis Diagnostic Tests Market, By Regions, 2021 €" 2033 (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022€"2033
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, By Test Type, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- Market Size and Forecast, By End User, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, By Test Type, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- Market Size and Forecast, By End User, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Test Type, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- Market Size and Forecast, By End User, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, By Test Type, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- Market Size and Forecast, By End User, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, By Test Type, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- Market Size and Forecast, By End User, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Test Type, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- Market Size and Forecast, By End User, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- Market Size and Forecast, By Country, and Y-o-Y Growth 2021 €" 2033, (US$ Mn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Company Profiles
- Abbott Diagnostics (Abbott Laboratories) *
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Labcorp
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Antibodies Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Networks LLC
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Beckman Coulter, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Euro Diagnostica AB, F.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Hoffmann-La Roche Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Qiagen NV
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Siemens Healthcare GmbH
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Augurex Life Sciences Corp.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Thermo Fisher Scientific Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Bio Rad Laboratories Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Exagen Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Genway Biotech, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Microdrop LLC (imaware)
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Svar Life Science AB
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Thermo Fisher Scientific Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Abbott Diagnostics (Abbott Laboratories) *
9. Section
- References
- Research Methodology
- About us and Sales Contact
